Updated recommendations in Germany challenge four widespread misconceptions about the menopause. The 2026 revised S3 guideline on “peri- and postmenopause”, along with statements from the German Menopause Society and information from the Federal Ministry of Health, provide an evidence-based account of its duration, symptoms and treatment (as at 8 November 2026).
Fact 1 – “The menopause only lasts a short time”: medically, menopause is considered to have occurred when menstruation has stopped for 12 months. However, the entire transition—from the hormonal changes before menopause through perimenopause and into postmenopause—can last many years. Symptoms such as hot flushes, sleep problems, mood swings or vaginal dryness vary from person to person and can persist for a long time.
Fact 2 – “The menopause is an illness”: hormonal change is a normal stage of life. Nevertheless, its effects can significantly impair quality of life. Guidelines therefore recommend seeking medical advice about symptoms and treating them on an individual basis. This does not change the fact that menopause itself is not a disease.
Fact 3 – “Hormones are always dangerous”: sweeping judgements about hormone therapy are considered outdated. The S3 guideline recommends an individual assessment of benefits and risks. For women under about 60 or in early postmenopause, oestrogen-based hormone therapy can be effective and safe for severe symptoms, provided contraindications are taken into account and the preparations and methods of administration are appropriately selected. Age, pre-existing conditions, risk profiles and treatment goals are decisive.
Fact 4 – “Lifestyle is always enough”: Exercise, a balanced diet, avoiding nicotine and good sleep hygiene help in many cases, but do not necessarily replace medical treatment when symptoms are severe or prolonged. Medical advice remains essential, including to identify coexisting conditions such as osteoporosis and address cardiovascular risks.
The S3 guideline is the authoritative basis for diagnostic and treatment decisions in the German healthcare system. The German Menopause Society and independent patient information services bring together practical guidance for people affected and healthcare teams. The Federal Ministry of Health is also supporting awareness-raising and dialogue about support in the workplace. Clear communication about duration, risks and treatment options – with specific age details and documented health status – is intended to prevent misunderstandings.
Attributed statements and forecasts should be distinguished: the recommendations cited come from the S3 guideline and statements by professional associations; individual treatment decisions are made by the treating practice together with the patient.
Editor: Clara Simonichek (Article created with AI assistance).